Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,972 public trials 2,027 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma

NCT06101381

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Hospital de Clínicas da UNICAMP Campinas, São Paulo, Brazil

Ribeirao Preto School of Medicine, University of Sao Paulo Ribeirão Preto, São Paulo, Brazil

Hospital Sírio-Libanês São Paulo, Brazil

Hospital das Clinicas de São Paulo São Paulo, Brazil

View Trial Details

Recruiting

The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia

NCT06236373

Conditions: Blood Protein Disorders, Breast Cancer, Breast Diseases, +46 more
Locations: Casa della Salute ex Spallanzani Reggio Emilia, Italy

View Trial Details

Recruiting

Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia

NCT06722638

Conditions: Acute Lymphoblastic Leukemia, Pediatric, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

View Trial Details

Recruiting

Prospective Evaluation of the Prognostic Impact of Measurable Residual Disease (MRD) Within a Phase III Study Comparing a Fixed Duration Therapy Versus Continuous Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma Requiring a First Salvage Treatment.

NCT05203003

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Department of Hematology, Hospital Saint Antoine Paris, France

View Trial Details

Recruiting

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

NCT05476770

Conditions: ALL, AML, Acute Undifferentiated Leukemia, +30 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital Orange County Orange, California, United States

UCSF School of Medicine San Francisco, California, United States

Children's Hospital Colorado Denver, Colorado, United States

View all 31 locations

View Trial Details

Recruiting

An Italian Multicenter Retrospective Observational Study to Assess Effectiveness and Safety of Siltuximab for Patients with Castleman's Disease Treated in Italy in a Real-life Context

NCT06720870

Conditions: Castleman Disease, Hemic and Lymphatic Diseases, Immune System Diseases, +3 more
Locations: IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy

Azienda Ospedaliera Sant'Anna e San Sebastiano Caserta, Italy

Policlinico di Bari - Azienda Ospedaliero Universitaria Consorziale Policlinico Bari, Italy

Azienda Ospedaliera Universitaria Arcispedale Sant'Anna Ferrara, Italy

View Trial Details

Recruiting

A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma

NCT06700395

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Zhongshan Hospital of Fudan University Shanghai, Shanghai Municipality, China

West China hospital, Sichuan university Chengdu, Sichuan, China

View Trial Details

Recruiting

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research

NCT06716164

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.

NCT04533217

Conditions: Back Injuries, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Center for Spine Surgery and Research Middelfart, Region Syddanmark, Denmark

View Trial Details

Recruiting

Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)

NCT06534463

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Shanghai Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions